Nasdaq:LFST
LifeStance Health Group, Inc.
LifeStance Health connects patients with licensed mental health professionals via a scalable digital platform across the US.
Key Metrics
Investment Thesis
Bull Case
Investors may buy this stock based on its recent path to profitability combined with a massive total addressable market for digital mental health services, which is projected to grow significantly as stigma decreases and insurance coverage expands. The substantial cash position of $248.6M provides ample runway for strategic acquisitions or R&D investments without immediate dilution concerns, positioning the company well against competitors.
Bear Case
The historical retained earnings deficit of over $800M indicates a prolonged history of burning capital that may still impact future cash flow stability despite current profits. High accounts payable levels relative to receivables and significant depreciation expenses suggest heavy reliance on intangible assets and potential asset write-down risks if market share gains slow down.
About LifeStance Health Group, Inc.
LifeStance Health Group is a leading digital health platform connecting patients with licensed mental health professionals across the United States. The company operates primarily through its mobile-first telehealth application and network of care managers, serving individuals seeking behavioral health support. Revenue streams include subscription fees from employers and insurance payers alongside direct-to-consumer patient access models.
Analysis
Management Discussion
The company successfully transitioned to profitability in 2025 with $9.7M net income following five years of investment in market penetration, while cash flow from operations surged to $146.2M indicating strong operational efficiency. However, the significant increase in accounts receivable by $36.1M suggests aggressive sales growth that requires careful monitoring of collection cycles and working capital management.
Industry Overview
The digital mental health industry is experiencing rapid expansion driven by post-pandemic demand, shortage of traditional therapists, and increasing insurance mandates for behavioral health coverage. This sector benefits from scalable technology platforms that can lower barriers to entry while maintaining high margins once customer acquisition costs are optimized.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $859.5M | $1.06B | $1.25B | $1.42B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $859.5M | $1.06B | $1.25B | $1.42B |
| Operating Expenses | $1.07B | $1.24B | $1.28B | $1.40B |
| Operating Income | $-210.2M | $-189.1M | $-31.6M | $24.1M |
| G&A | $378.0M | $410.8M | $363.1M | $382.2M |
| Stock-Based Comp | $187.4M | $99.4M | $76.2M | $74.7M |
| D&A | $28.9M | $37.4M | $40.7M | $41.6M |
| Amortization | $40.3M | $43.1M | $30.3M | $13.1M |
| Other OpEx | $691.7M | $834.0M | $919.5M | $1.02B |
| Non-Operating Income | $-22.6M | $-17.4M | $-26.0M | $-11.8M |
| Interest Expense | $19.9M | $21.2M | $26.5M | $11.7M |
| Pre-Tax Income | $-232.7M | $-206.6M | $-57.6M | $12.4M |
| Income Tax | $-17.2M | $-20.3M | $-170.0K | $2.7M |
| Continuing Ops | $-215.6M | $-186.3M | $-57.4M | $9.7M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $-215.6M | $-186.3M | $-57.4M | $9.7M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $-215.6M | $-186.3M | $-57.4M | $9.7M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $233.2M | $225.7M | $312.5M | $416.2M |
| Cash & Equivalents | $108.6M | $78.8M | $154.6M | $248.6M |
| Accounts Receivable | $100.9M | $125.4M | $131.8M | $95.7M |
| Prepaid Expenses | $23.7M | $21.5M | $26.1M | $71.8M |
| Other Current Assets | $0 | $0 | $0 | $0 |
| Long-Term Assets | $1.94B | $1.88B | $1.81B | $1.79B |
| PP&E (Net) | $194.2M | $188.2M | $166.0M | $161.6M |
| Intangibles | $263.3M | $221.1M | $190.8M | $177.7M |
| Goodwill | $1.27B | $1.29B | $1.29B | $1.29B |
| Operating Leases | $199.4M | $170.7M | $147.9M | $149.7M |
| Other LT Assets | $10.8M | $10.9M | $7.7M | $5.4M |
| Total Assets | $2.17B | $2.11B | $2.12B | $2.20B |
| Current Liabilities | $176.0M | $202.9M | $228.9M | $252.0M |
| Accounts Payable | $12.3M | $7.1M | $7.2M | $6.1M |
| Current Debt | $2.3M | $2.9M | $7.2M | $14.5M |
| Current Leases | $38.8M | $46.5M | $49.4M | $45.5M |
| Other Current Liab | $92.1M | $111.4M | $118.0M | $143.6M |
| Long-Term Liabilities | $479.1M | $478.2M | $443.1M | $431.0M |
| Long-Term Debt | $225.1M | $280.3M | $279.8M | $265.9M |
| LT Operating Leases | $212.6M | $181.4M | $148.7M | $148.6M |
| Other LT Liab | $41.5M | $16.5M | $14.6M | $16.5M |
| Total Liabilities | $655.1M | $681.0M | $672.0M | $682.9M |
| Shareholders' Equity | $1.52B | $1.43B | $1.45B | $1.52B |
| Retained Earnings | $-572.6M | $-760.8M | $-818.3M | $-808.6M |
| AOCI | $3.3M | $2.3M | $929.0K | $0 |
| Total L&E | $2.17B | $2.11B | $2.12B | $2.20B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-215.6M | $-186.3M | $-57.4M | $9.7M |
| Non-Cash Adjustments | $238.7M | $133.0M | $126.8M | $105.1M |
| Working Capital Changes | $29.7M | $36.4M | $37.9M | $31.4M |
| Cash from Operations | $52.8M | $-16.9M | $107.3M | $146.2M |
| Capital Expenditures | $79.3M | $40.5M | $21.6M | $36.1M |
| Cash from Investing | $-139.5M | $-60.3M | $-21.6M | $-36.1M |
| Debt Issuances | $257.3M | $57.8M | $287.8M | $0 |
| Debt Repayments | $187.8M | $2.5M | $289.5M | $7.2M |
| Cash from Financing | $47.3M | $47.4M | $-9.9M | $-16.0M |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-39.4M | $-29.8M | $75.7M | $94.1M |
| Beginning Cash | $148.0M | $108.6M | $78.8M | $154.6M |
| Ending Cash | $108.6M | $78.8M | $154.6M | $248.6M |
Frequently Asked Questions
How does LifeStance Health Group, Inc. make money?
Direct-to-Consumer (DTC) subscriptions where patients pay monthly for therapy access, Employer Solutions providing behavioral health programs to corporations, Insurance Payer contracts reimbursing for covered teletherapy sessions, and Clinical Services including care management and assessment tools.
What are the main risks for LFST?
Regulatory uncertainty regarding telehealth reimbursement rates across different US states and federal programs, intense competition from established digital health giants like Teladoc and emerging AI-driven therapy startups, potential margin compression if acquisition costs or customer acquisition expenses rise faster than revenue growth, and cybersecurity risks inherent in handling sensitive patient mental health data.
What is LFST's competitive advantage?
First-mover advantage in a fragmented market with over 100 million uninsured or underinsured patients needing mental health care, proprietary technology that integrates seamlessly with Electronic Health Records (EHRs), and a rapidly scaling network of licensed clinicians that reduces provider friction compared to traditional staffing models.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.